JP2018525093A - グルコース目標の自動適合を備えたグルコース制御システム - Google Patents

グルコース目標の自動適合を備えたグルコース制御システム Download PDF

Info

Publication number
JP2018525093A
JP2018525093A JP2018506198A JP2018506198A JP2018525093A JP 2018525093 A JP2018525093 A JP 2018525093A JP 2018506198 A JP2018506198 A JP 2018506198A JP 2018506198 A JP2018506198 A JP 2018506198A JP 2018525093 A JP2018525093 A JP 2018525093A
Authority
JP
Japan
Prior art keywords
glucose
glucose level
sensor
dose
level signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018506198A
Other languages
English (en)
Japanese (ja)
Inventor
フィラス エル−カティーブ，
フィラス エル−カティーブ，
エドワード ダミアーノ，
エドワード ダミアーノ，
スティーブン ジェイ． ラッセル，
スティーブン ジェイ． ラッセル，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Publication of JP2018525093A publication Critical patent/JP2018525093A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2018506198A 2015-08-07 2016-08-08 グルコース目標の自動適合を備えたグルコース制御システム Pending JP2018525093A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562202505P 2015-08-07 2015-08-07
US62/202,505 2015-08-07
PCT/US2016/046008 WO2017027459A1 (en) 2015-08-07 2016-08-08 Glucose control system with automatic adaptation of glucose target

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020090703A Division JP7048666B2 (ja) 2015-08-07 2020-05-25 グルコース目標の自動適合を備えたグルコース制御システム

Publications (1)

Publication Number Publication Date
JP2018525093A true JP2018525093A (ja) 2018-09-06

Family

ID=57983555

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018506198A Pending JP2018525093A (ja) 2015-08-07 2016-08-08 グルコース目標の自動適合を備えたグルコース制御システム
JP2020090703A Active JP7048666B2 (ja) 2015-08-07 2020-05-25 グルコース目標の自動適合を備えたグルコース制御システム
JP2022049164A Active JP7488293B2 (ja) 2015-08-07 2022-03-24 グルコース目標の自動適合を備えたグルコース制御システム
JP2024076848A Pending JP2024096420A (ja) 2015-08-07 2024-05-09 グルコース目標の自動適合を備えたグルコース制御システム

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020090703A Active JP7048666B2 (ja) 2015-08-07 2020-05-25 グルコース目標の自動適合を備えたグルコース制御システム
JP2022049164A Active JP7488293B2 (ja) 2015-08-07 2022-03-24 グルコース目標の自動適合を備えたグルコース制御システム
JP2024076848A Pending JP2024096420A (ja) 2015-08-07 2024-05-09 グルコース目標の自動適合を備えたグルコース制御システム

Country Status (5)

Country Link
US (4) US10842934B2 (https=)
EP (2) EP3957233A3 (https=)
JP (4) JP2018525093A (https=)
DK (1) DK3319511T3 (https=)
WO (1) WO2017027459A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022541659A (ja) * 2019-07-25 2022-09-26 コミサリア ア エナジー アトミック エ オックス エナジーズ オルタネティヴ 血糖レベルを制御するための自動化システム

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4233936A3 (en) 2014-06-10 2023-11-01 Bigfoot Biomedical, Inc. Insulin delivery systems and methods
WO2017027459A1 (en) 2015-08-07 2017-02-16 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10413658B2 (en) 2017-03-31 2019-09-17 Capillary Biomedical, Inc. Helical insertion infusion device
CN106983951A (zh) * 2017-05-04 2017-07-28 梁曦 一种分析物监测与自动给药系统
JP6874155B2 (ja) 2017-05-05 2021-05-19 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
WO2019125932A1 (en) * 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
WO2020097552A1 (en) 2018-11-08 2020-05-14 Capillary Biomedical, Inc Linear insertion device with rotational drive
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
EP3998943A4 (en) 2019-07-16 2023-09-06 Beta Bionics, Inc. Blood glucose control system
CN114868200A (zh) 2019-10-04 2022-08-05 贝塔仿生公司 血糖控制系统
WO2022140204A1 (en) 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US12214159B2 (en) 2020-08-28 2025-02-04 Tandem Diabetes Care, Inc Insulin infusion set
US11594314B2 (en) 2020-12-07 2023-02-28 Beta Bionics, Inc. Modular blood glucose control systems
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
WO2022234032A2 (en) * 2021-05-05 2022-11-10 Novo Nordisk A/S Methods and systems for estimating fasting glucose values

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208113A1 (en) * 2005-05-13 2008-08-28 Trustees Of Boston University Fully Automated Control System for Type I Diabetes
JP2012519018A (ja) * 2009-02-26 2012-08-23 モール・リサーチ・アプリケーションズ・リミテッド 糖尿病に関連した治療を自動モニタリングする方法およびシステム
JP2014500051A (ja) * 2010-10-31 2014-01-09 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
WO2014110541A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US20150217052A1 (en) * 2014-02-06 2015-08-06 Medtronic Minimed, Inc Automatic closed-loop control adjustments and infusion systems incorporating same

Family Cites Families (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241704B1 (en) 1901-11-22 2001-06-05 Sims Deltec, Inc. Drug pump systems and methods
US4280494A (en) 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
EP0374140A1 (en) 1987-08-28 1990-06-27 The Regents Of The University Of Minnesota Metabolic sensor for a drug delivery system
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
DE10006044A1 (de) 2000-02-10 2001-08-16 Roche Diagnostics Gmbh Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US7460130B2 (en) 2000-09-26 2008-12-02 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US6852104B2 (en) 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
DE60328039D1 (de) 2002-10-11 2009-07-30 Becton Dickinson Co Insulinabgabesystem mit Sensor
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US9872890B2 (en) 2003-03-19 2018-01-23 Paul C. Davidson Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US20050182366A1 (en) 2003-04-18 2005-08-18 Insulet Corporation Method For Visual Output Verification
US20040253736A1 (en) 2003-06-06 2004-12-16 Phil Stout Analytical device with prediction module and related methods
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
DE102004011135A1 (de) 2004-03-08 2005-09-29 Disetronic Licensing Ag Verfahren und Vorrichtung zum Berechnen einer Bolusmenge
WO2005113036A1 (en) 2004-05-13 2005-12-01 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
US7727147B1 (en) 2004-05-14 2010-06-01 Flint Hills Scientific Llc Method and system for implantable glucose monitoring and control of a glycemic state of a subject
US20060272652A1 (en) 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US20060276771A1 (en) 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
CN100446724C (zh) 2005-11-28 2008-12-31 中国科学院电子学研究所 用于闭环胰岛素注射的无创血糖仪
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US20070255126A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Data communication in networked fluid infusion systems
JP4918285B2 (ja) 2006-05-24 2012-04-18 シスメックス株式会社 生体器官の機能のシミュレーションシステム及びそのプログラム
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
US20110054391A1 (en) 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
WO2008057384A2 (en) 2006-11-02 2008-05-15 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate
US7654127B2 (en) 2006-12-21 2010-02-02 Lifescan, Inc. Malfunction detection in infusion pumps
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
AU2008227836A1 (en) 2007-03-19 2008-09-25 Medingo Ltd. User interface for selecting bolus doses in a drug delivery device
EP1983456B1 (de) 2007-04-19 2013-08-14 F.Hoffmann-La Roche Ag Verfahren zum Einstellen eines Basalratenprofils für eine Insulinpumpe
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US20100145262A1 (en) 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
EP2174128B8 (en) 2007-06-20 2017-01-11 Roche Diabetes Care GmbH Method and device for assessing carbohydrate-to-insulin ratio
EP2166946B1 (en) 2007-06-21 2019-11-20 University Of Virginia Patent Foundation Lqg artificial pancreas control system and related method
WO2009001349A1 (en) 2007-06-25 2008-12-31 Medingo Ltd. Tailored basal insulin delivery system
EP2562664B1 (en) 2007-06-27 2020-11-25 Roche Diabetes Care GmbH System for determining an insulin delivery and communicating a dose in automated pancreas software
US20090036753A1 (en) 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
CN102670209A (zh) 2007-09-07 2012-09-19 泰尔茂株式会社 血糖值测量方法
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
WO2009059187A1 (en) 2007-11-02 2009-05-07 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090177154A1 (en) 2008-01-08 2009-07-09 Michael Blomquist Insulin pump with convenience features
US20090177142A1 (en) 2008-01-09 2009-07-09 Smiths Medical Md, Inc Insulin pump with add-on modules
CA2720304C (en) 2008-04-04 2018-05-15 Hygieia, Inc. Apparatus for optimizing a patient's insulin dosage regimen
CN201186082Y (zh) 2008-05-05 2009-01-28 王安宇 胰岛素、葡萄糖智能输入装置
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8527208B2 (en) 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
CN102369032B (zh) 2009-02-04 2015-09-30 赛诺菲-安万特德国有限公司 用于提供用于血糖控制的信息的医疗系统和方法
BRPI1008842B1 (pt) 2009-02-04 2021-04-13 Sanofi-Aventis Deutschland Gmbh Dispositivo e método médicos para proporcionarem um controle glicêmico com base em informações de resposta glicêmica
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
US20100256466A1 (en) 2009-04-02 2010-10-07 Avraham Shekalim Metabolite Management System
EP2435962B1 (en) 2009-05-29 2023-04-19 University of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
DK3173014T4 (da) 2009-07-23 2026-03-30 Abbott Diabetes Care Inc Realtidsstyring af data vedrørende fysiologisk kontrol af glucoseniveauer
WO2011028731A1 (en) 2009-09-01 2011-03-10 University Of Virginia Patent Foundation System, method and computer program product for adjustment of insulin delivery (aid) in diabetes using nominal open-loop profiles
WO2011033509A1 (en) 2009-09-18 2011-03-24 Medingo Ltd. Devices, systems and methods for quantifying bolus doses according to user parameters
JP5728767B2 (ja) 2009-09-30 2015-06-03 ドリームド・ダイアベティス・リミテッド インスリン送達の管理のための監視システム、方法、およびコンピュータプログラム
US8690820B2 (en) 2009-10-06 2014-04-08 Illinois Institute Of Technology Automatic insulin pumps using recursive multivariable models and adaptive control algorithms
US20110098638A1 (en) 2009-10-27 2011-04-28 Medtronic Minimed, Inc. Sensor-Augmented Medication Infusion System
CA2779479C (en) 2009-11-04 2020-03-31 Hygieia Inc. Apparatus and methods for taking blood glucose measurements and recommending insulin doses
EP2496289A4 (en) 2009-11-04 2013-06-26 Aimedics Pty Ltd SYSTEM AND METHOD FOR INTEGRATING HYPOGLY KEMIA ALARMS THROUGH COLLECTED DATA IN GLYCOME CONTROL SYSTEMS WITH CLOSED CONTROL CIRCUITS
JP5750123B2 (ja) 2010-02-11 2015-07-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 生物学的因子又は薬物を被検者に送達するためのシステム、装置及び方法
US8579879B2 (en) 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
EP4183326B1 (en) 2010-03-26 2026-01-28 University Of Virginia Patent Foundation Method, system, and computer program product for improving the accuracy of glucose sensors using insulin delivery observation in diabetes
US9445757B2 (en) 2010-12-29 2016-09-20 Medtronic Minimed, Inc. Glycemic health metric determination and application
AU2012272668B2 (en) 2011-06-23 2017-02-02 University Of Virginia Patent Foundation Unified platform for monitoring and control of blood glucose levels in diabetic patients
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
US10694983B2 (en) 2012-01-19 2020-06-30 Medtronic Minimed, Inc. Method and/or system for assessing a patient's glycemic response
US9883834B2 (en) 2012-04-16 2018-02-06 Farid Amirouche Medication delivery device with multi-reservoir cartridge system and related methods of use
US9238100B2 (en) 2012-06-07 2016-01-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9901677B2 (en) 2012-10-16 2018-02-27 Bigfoot Biomedical, Inc. Infusion pump system and methods
US9486578B2 (en) 2012-12-07 2016-11-08 Animas Corporation Method and system for tuning a closed-loop controller for an artificial pancreas
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US9492608B2 (en) 2013-03-15 2016-11-15 Tandem Diabetes Care, Inc. Method and device utilizing insulin delivery protocols
US9517306B2 (en) 2013-03-15 2016-12-13 Animas Corporation Method and system for closed-loop control of an artificial pancreas
WO2015021041A2 (en) 2013-08-05 2015-02-12 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
EP2851823A1 (en) 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
EP3089667B1 (en) 2014-01-31 2022-04-13 Trustees of Boston University Offline glucose control based on preceding periods
EP3148419A4 (en) 2014-05-27 2018-01-24 ResMed Limited Remote respiratory therapy device management
EP4233936A3 (en) 2014-06-10 2023-11-01 Bigfoot Biomedical, Inc. Insulin delivery systems and methods
CN104667379B (zh) 2015-03-06 2017-08-15 上海交通大学 动态闭环控制的胰岛素泵
CN104667368B (zh) 2015-03-06 2017-08-15 上海交通大学 控制与计算分离的胰岛素泵动态控制实现方法
WO2017027459A1 (en) 2015-08-07 2017-02-16 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US20200254240A1 (en) 2016-05-15 2020-08-13 Biolinq, Inc. Devices and Methods For The Incorporation Of A Microneedle Array Analyte-Selective Sensor Into An Infusion Set, Patch Pump, Or Automated Therapeutic Delivery System
US10937536B2 (en) 2016-07-15 2021-03-02 Universität Bern Estimation of insulin based on reinforcement learning
US10994077B2 (en) 2016-07-21 2021-05-04 Tandem Diabetes Care, Inc. Enhanced confirmations for touchscreen infusion pump
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
EP3600519A4 (en) 2017-03-29 2021-01-13 Becton, Dickinson and Company SYSTEM AND METHOD FOR OPERATING THE CONTROL DEVICE OF A DISPENSING DEVICE WITH FLASHES AND TAPS TO CONFIRM A FUNCTION
US11147920B2 (en) 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US10887795B2 (en) 2018-12-13 2021-01-05 Fortinet, Inc. Over-the-air (OTA) Wi-Fi offloading
EP3998943A4 (en) 2019-07-16 2023-09-06 Beta Bionics, Inc. Blood glucose control system
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208113A1 (en) * 2005-05-13 2008-08-28 Trustees Of Boston University Fully Automated Control System for Type I Diabetes
JP2012519018A (ja) * 2009-02-26 2012-08-23 モール・リサーチ・アプリケーションズ・リミテッド 糖尿病に関連した治療を自動モニタリングする方法およびシステム
JP2014500051A (ja) * 2010-10-31 2014-01-09 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
WO2014110541A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US20150217052A1 (en) * 2014-02-06 2015-08-06 Medtronic Minimed, Inc Automatic closed-loop control adjustments and infusion systems incorporating same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022541659A (ja) * 2019-07-25 2022-09-26 コミサリア ア エナジー アトミック エ オックス エナジーズ オルタネティヴ 血糖レベルを制御するための自動化システム
JP7696885B2 (ja) 2019-07-25 2025-06-23 コミサリア ア エナジー アトミック エ オックス エナジーズ オルタネティヴ 血糖レベルを制御するための自動化システム

Also Published As

Publication number Publication date
JP2020142112A (ja) 2020-09-10
US11744945B2 (en) 2023-09-05
WO2017027459A1 (en) 2017-02-16
US10842934B2 (en) 2020-11-24
JP2024096420A (ja) 2024-07-12
US20250303063A1 (en) 2025-10-02
US20240165327A1 (en) 2024-05-23
EP3957233A3 (en) 2022-05-11
EP3319511B1 (en) 2021-10-06
JP2022075971A (ja) 2022-05-18
DK3319511T3 (da) 2021-11-01
EP3319511A4 (en) 2019-03-20
US20180220942A1 (en) 2018-08-09
EP3319511A1 (en) 2018-05-16
CA2993830A1 (en) 2017-02-16
JP7488293B2 (ja) 2024-05-21
US12280241B2 (en) 2025-04-22
JP7048666B2 (ja) 2022-04-05
US20210106755A1 (en) 2021-04-15
EP3957233A2 (en) 2022-02-23

Similar Documents

Publication Publication Date Title
JP7488293B2 (ja) グルコース目標の自動適合を備えたグルコース制御システム
USRE50075E1 (en) Glucose level control system with offline control based on preceding periods of online control
USRE50080E1 (en) Blood glucose control system
JP5389147B2 (ja) １型糖尿病用の完全自動制御システム
CA2993830C (en) Glucose control system with automatic adaptation of glucose target
US20260066081A1 (en) Adjustment of glucose control parameter(s) based on bolus medicament delivery data

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180302

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180529

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190408

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190610

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200324

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200714